BUDGET AND CLINICAL IMPACT OF PRIMARY SCREENING WITH HR-HPV GENOTYPING TEST AND TRIAGE WITH P16/KI-67 DUAL-STAINED CYTOLOGY FOR CERVICAL CANCER IN THE MEXICAN PUBLIC HEALTH CARE SETTING
May 1, 2016, 00:00
10.1016/j.jval.2016.03.695
https://www.valueinhealthjournal.com/article/S1098-3015(16)00763-4/fulltext
Title :
BUDGET AND CLINICAL IMPACT OF PRIMARY SCREENING WITH HR-HPV GENOTYPING TEST AND TRIAGE WITH P16/KI-67 DUAL-STAINED CYTOLOGY FOR CERVICAL CANCER IN THE MEXICAN PUBLIC HEALTH CARE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00763-4&doi=10.1016/j.jval.2016.03.695
First page :
A300
Section Title :
Medical Device/Diagnostics - Cost Studies
Open access? :
No
Section Order :
1244